Synthego Stock

synthego.comBioTechFounded: 2012Funding to Date: $270.91MM

Synthego is a genome engineering company leveraging machine learning, automation, and gene editing to build platforms for science at scale.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Synthego, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Paul Dabrowski
Co-Founder, Chief Executive Officer & Board Member
Michael Dabrowski
Co-Founder, President & Board Member
Forrest Baringer-Jones
Chief Financial Officer

Board Members

Michael Dabrowski
Paul Dabrowski
Drew Oetting
8VC
Scott Nolan
Founders Fund

Other companies like Synthego in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$289.42MM

News

Synthego, a startup developing a platform for gene editing experiments, has raised an additional $100 million to advance its work.
Even Crispr babies have a global supply chain.